Scripps Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
29
About the Report
About the Report
Summary
Scripps Health (Scripps) is a non-profit healthcare organization, which provides healthcare services including primary care and urgent and emergency care services; preventive services and wellness screening services. The organization offers specialized medical care with medical departments in most of the major medical and surgical specialties. It operates major acute care facilities in its campuses including Scripps Green Hospital; Scripps Memorial Hospital Encinitas and La Jolla; and Scripps Mercy Hospital. It has a network of integrated facilities, outpatient centers and clinics under Scripps Clinic and Scripps Coastal Medical Center. It also operates Prebys Cardiovascular Institute for heart care. It offers Scripps Home Health Care services, Scripps Hospice and a range of health education classes and support services. Scripps is headquartered in San Diego, California, the US.
Scripps Health-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scripps Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scripps Health, Medical Devices Deals, 2012 to YTD 2018 8
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scripps Health, Pharmaceuticals & Healthcare, Deal Details 10
Debt Offering 10
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2032 For USD 21.7 Million 10
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 80 Million 11
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2035 For USD 35.7 Million 12
Scripps Health Completes Public Offering Of Bonds Due 2021 For USD 2.2 Million 13
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2022 For USD 1.7 Million 14
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 3.8 Million 15
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 5.3 Million 16
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 5.4 Million 17
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 5.6 Million 18
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2027 For USD 5.8 Million 19
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2028 For USD 4.3 Million 20
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2029 For USD 4.5 Million 21
Acquisition 22
Scripps Health Plans To Acquire El Centro Regional Medical Center 22
Scripps Health-Key Competitors 23
Scripps Health-Key Employees 24
Scripps Health-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Legal and Regulatory 28
Jan 19, 2018: Sanford Heisler Sharp Settles USD 1.5 Million Whistleblower Suit Against Scripps Health System 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Figure
List of Figures
Scripps Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scripps Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scripps Health, Medical Devices Deals, 2012 to YTD 2018 8
List of Table
List of Tables
Scripps Health, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scripps Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scripps Health, Medical Devices Deals, 2012 to YTD 2018 8
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2032 For USD 21.7 Million 10
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 80 Million 11
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2035 For USD 35.7 Million 12
Scripps Health Completes Public Offering Of Bonds Due 2021 For USD 2.2 Million 13
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2022 For USD 1.7 Million 14
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 3.8 Million 15
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 5.3 Million 16
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 5.4 Million 17
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 5.6 Million 18
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2027 For USD 5.8 Million 19
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2028 For USD 4.3 Million 20
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2029 For USD 4.5 Million 21
Scripps Health Plans To Acquire El Centro Regional Medical Center 22
Scripps Health, Key Competitors 23
Scripps Health, Key Employees 24
Scripps Health, Other Locations 26
Scripps Health, Subsidiaries 27
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.